Evidence against KSHV infection in the pathogenesis of multiple myeloma.
暂无分享,去创建一个
K. Tarte | B. Klein | S. Olsen | Y. Chang | W. Sherman | A. Orazi | M. Weisse | E. E. Hale
[1] K. Tarte,et al. Clinical-grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi's sarcoma-associated herpesvirus. , 1998, Blood.
[2] M. Moroni,et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. , 1997, Science.
[3] G. Pinkus,et al. Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. , 1997, Blood.
[4] K. Tarte,et al. Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma. , 1997, Blood.
[5] G. Morgan,et al. HHV-8 and multiple myeloma in the UK , 1997, The Lancet.
[6] V. Calvez,et al. HHV-8 and multiple myeloma in France , 1997, The Lancet.
[7] L. Rainbow,et al. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen , 1997, Journal of virology.
[8] J. Said,et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. , 1997, Science.
[9] R. Sun,et al. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells , 1997, Journal of virology.
[10] C. Boshoff,et al. Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.
[11] P. Simmonds,et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.
[12] J. Phair,et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.
[13] J. Phair,et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. , 1996, The New England journal of medicine.
[14] T. Rose,et al. Detection and analysis of diverse herpesviral species by consensus primer PCR , 1996, Journal of clinical microbiology.
[15] D R Hoover,et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.
[16] G. Gaidano,et al. Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain , 1995, British journal of haematology.
[17] F. Sigaux,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.
[18] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[19] B. Klein,et al. Interleukin-6 in human multiple myeloma. , 1995, Blood.
[20] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[21] H. Haverkos,et al. Prevalence of Kaposi's sarcoma among patients with AIDS. , 1985, The New England journal of medicine.
[22] C. Boshoff,et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. , 1997, Science.
[23] O. Cope,et al. Multiple myeloma. , 1948, The New England journal of medicine.